DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today ...

But the inability to find these replication studies easily wastes research time and resources. If scientists aren't aware of ...

Understanding the origin of life requires addressing a collection of overlapping scientific questions. We’ve made a lot of progress toward explaining how simple chemicals present on an early Earth ...

Tiny, quivering spheres designed to feed and multiply raise prospect of artificial organisms to make drugs, food and fuel Researchers claim they are closer to creating life from scratch after building ...

A security analyst at a large enterprise recently found sensitive HR documents being copied into a Microsoft Teams channel that hundreds of employees could access. It was not caused by a malicious ...

YouTube content creation often feels like a guessing game, but a new strategy empowers creators to use ChatGPT for data-driven success. The AI transforms instinct into evidence by analyzing competitor ...

AI vulnerability scanning is moving into developer workflows. Claude Security turns findings into prioritized fix guidance. The big challenge is keeping these tools from attackers. Anthropic has ...

The app, which allows casts and crews to mark up and revise scripts digitally, has diverted more than 120 million sheets from production sets worldwide over the past three years. By Kirsten Chuba ...

Office Scripts in Excel Online provide a practical way to automate repetitive tasks and streamline workflows. By using TypeScript and the Excel Document Object Model (DOM), users can programmatically ...

Keep each script version focused on a single change type (patches for fixes, minors for features, majors for breaking changes). Retain all prior versions and never modify an existing release; copy to ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...